Royce & Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.87M | Hold |
|
|||||
|
2025
Q1 | $3.08M | Hold |
|
|||||
|
2024
Q4 | $3.53M | Hold |
|
|||||
|
2024
Q3 | $3.58M | Hold |
|
|||||
|
2024
Q2 | $3.19M | Hold |
|
|||||
|
2024
Q1 | $2.3M | Hold |
|
|||||
|
2023
Q4 | $2.2M | Hold |
|
|||||
|
2023
Q3 | $2.26M | Hold |
|
|||||
|
2023
Q2 | $2.21M | Hold |
|
|||||
|
2023
Q1 | $2.24M | Hold |
|
|||||
|
2022
Q4 | $2.78M | Hold |
|
|||||
|
2022
Q3 | $2.09M | Hold |
|
|||||
|
2022
Q2 | $2.36M | Hold |
|
|||||
|
2022
Q1 | $1.79M | Hold |
|
|||||
|
2021
Q4 | $2.16M | Sell |
|
|||||
|
2021
Q3 | $19M | Sell |
|
|||||
|
2021
Q2 | $39M | Sell |
|
|||||
|
2021
Q1 | $37.5M | Buy |
|
|||||
|
2020
Q4 | $21.7M | Buy |
|
|||||
|
2020
Q3 | $6.54M | Buy |
|